Portfolio Category: Lab Reports

E-cigarettes: Product characterization and design

Electronic cigarettes: product characterisation and design considerations

Christopher J Brown, James M Cheng Correspondence to Christopher J Brown, Center for Tobacco Products, U.S. Food and Drug Administration, Office of Science, 9200 Corporate Blvd, Rockville, MD 20850, USA; Christopher.Brown@fda.hhs.gov Received 3 December 2013 Accepted 4 March 2014 Full text of report in PDF format

Abstract

Objective To review the available evidence regarding electronic cigarette (e-cigarette) product characterisation and design features in order to...

Read more

Chemical evaluation of e-cigarettes

Tianrong Cheng

Correspondence to Dr Tianrong Cheng, Office of Science, Center for Tobacco Products, Food and Drug Administration, 9200 Corporate Blvd, Rockville, MD 20850, USA; Tianrong.Cheng@fda.hhs.gov Received 4 December 2013 Revised 27 February 2014 Accepted 28 February 2014

Abstract

Objective To review the available evidence evaluating the chemicals in refill solutions, cartridges, aerosols and environmental emissions of electronic cigarettes (e-cigarettes).

Methods Systematic literature searches were conducted to identify research related to e-cigarettes and chemistry using 5 reference databases and 11 search...

Read more

Cigarettes and nicotine pharmacology

Electronic cigarettes and nicotine clinical pharmacology

Megan J Schroeder, Allison C Hoffman Correspondence to Dr Megan J Schroeder, Office of Science/Center for Tobacco Products/FDA, 9200 Corporate Blvd, Rockville, MD 20850, USA; Megan.Schroeder@fda.hhs.gov Received 2 December 2013 Accepted 11 February 2014 Full text of report in PDF format

Abstract

Objective To review the available literature evaluating electronic cigarette (e-cigarette) nicotine clinical pharmacology in order to understand the potential impact of e-cigarettes on individual users, nicotine dependence and public health.